The Surefire Medical Blog

Clinical news, liver cancer topics, technology updates and Surefire Medical events.

Blog Test

Default post description

Clinical News

Clinical Data Shows Surefire Provides 80% Complete Response Rate

Clinical Data Shows Surefire Technology Provides 80% Complete Response Rate for Bridge-to-Transplant Primary Liver Cancer Treatment versus 52% for Standard Microcatheter

Achievement

Surefire Receives Regulatory Approval for Infusion Systems and Guiding Catheters in Mexico

Surefire will now market the Surefire Precision 021, Surefire Infusion System mT/LT, and Surefire Guiding Catheters in Mexico

Achievement

Surefire Technology Achieved 79% Objective Response

Clinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver Cancer. Study presented at SIR 2017 

Product

Surefire Medical Launches New Flexion Guiding Catheter

The New Flexion Guiding Catheter Includes a Nitinol Tip for Better Shape Retention and Improved Back-up Support